Puma Biotechnology, Inc. (PBYI)
6.37
-0.01
(-0.16%)
USD |
NASDAQ |
Jan 16, 16:00
6.37
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology EPS Diluted (Quarterly): 0.1736 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0305 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| CorMedix, Inc. | 1.259 |
| Relmada Therapeutics, Inc. | -0.304 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.844M |
| Revenue (Quarterly) | 54.48M |
| Total Expenses (Quarterly) | 45.63M |
| Enterprise Value | 265.56M |
| Gross Profit Margin (Quarterly) | 77.65% |
| Profit Margin (Quarterly) | 16.24% |
| Earnings Yield | 11.63% |
| Operating Earnings Yield | 10.52% |
| Normalized Earnings Yield | 11.63 |